The neurology devices market is forecast to expand at a CAGR of 7.46% from 2024 to 2030, a trajectory underpinned by structural demographic and epidemiological shifts rather than short-term demand fluctuations. Global dementia prevalence stood at approximately 55 million cases in 2020, per WHO estimates, while Parkinson's disease affected an estimated 8.5 million individuals in 2019. Compounding this disease burden is a rapidly aging global population: the WHO projects that by 2030, one in six people will be aged 60 or above. Against this backdrop, demand across neurostimulation, neurosurgery, cerebrospinal fluid management, and interventional neurology device categories is expected to remain robust. The neurostimulation segment in particular commands outsized revenue share, buoyed by regulatory milestones such as Abbott's clearance for its Proclaim Plus spinal cord stimulation system and Nevro Corp's FDA clearance for 10 kHz high-frequency therapy targeting painful diabetic neuropathy. Market leadership remains concentrated among established players, including Abbott, Medtronic, Boston Scientific, Stryker, and Koninklijke Philips.

India Neurology Devices Market

Expansion here is anchored in improving healthcare access, government-backed medical device innovation programs, and an escalating burden of neurological disease. The convergence of rising patient volumes and demand for advanced diagnostic and therapeutic solutions has drawn increased interest from both domestic manufacturers and multinational entrants, with strategic partnerships and new product introductions expected to sustain the market's growth trajectory.

UK Neurology Devices Market

A mature healthcare system and a strong clinical research base continue to underpin performance in this market. Favorable regulatory conditions, high uptake of advanced medical technologies, rising healthcare expenditure, and an institutional emphasis on patient-centered care collectively reinforce the UK's position as a material contributor to Europe's broader neurology device sector.

Spain Neurology Devices Market

Momentum is being sustained by improved public awareness, stronger diagnostic infrastructure, and healthcare policy reforms that favor specialized neurological treatment. Rising capital allocation toward dedicated neurology centers, alongside expanding footprints from device manufacturers, points to durable growth prospects ahead.

Italy Neurology Devices Market

An aging demographic profile combined with well-developed hospital infrastructure continues to generate consistent demand for neurological diagnostic and treatment technologies. Ongoing facility modernization, together with heightened clinical attention to conditions such as Parkinson's disease and stroke, is driving broader adoption of neurostimulation and neurosurgical equipment, reinforcing Italy's standing within the wider European landscape.

GCC Neurology Devices Market

Substantial government-led investment in healthcare modernization is accelerating adoption of advanced neurological care technologies across the Gulf region. This growth is further supported by international partnerships, infrastructure expansion, and the proliferation of specialized care centers, with improving diagnostic capacity expected to sustain the region's upward trend.

Vietnam Neurology Devices Market

As healthcare infrastructure matures across Southeast Asia, Vietnam is positioning itself as an increasingly relevant market for neurological diagnostic and treatment devices. Growing clinical awareness, an expanding hospital network, and rising capital commitments from domestic and international device manufacturers are steadily improving the availability of advanced neurology care nationwide.

Pediatric Neurology Device Market

Among the industry's segments, this one stands out for its pace of expansion, driven by the distinct neurological care requirements of pediatric populations. As early diagnosis assumes greater clinical priority, manufacturers are directing resources toward the development of safer, purpose-built devices for younger patients — a shift reinforced by rising case volumes globally.

US Pediatric Neurology Devices Market

Within the United States, the persistent burden of traumatic brain injury remains a defining growth driver: brain injuries occur at a rate of roughly one every nine seconds, translating to more than 3.5 million annual incidents, including approximately 2.8 million traumatic brain injury cases and 280,000 associated hospitalizations each year. This is compounded by an estimated 60,000 new Parkinson's disease diagnoses annually and an Alzheimer's disease population now exceeding 6 million Americans, a figure projected to nearly double by 2050. Taken together with a supportive regulatory environment and concentrated manufacturer presence, these dynamics are driving sustained investment in pediatric-focused neurological technologies.

Europe Pediatric Neurology Device Market

Across the continent, growing clinical recognition of early childhood neurological disorders, coupled with favorable reimbursement frameworks and healthcare reform across markets such as the UK, Spain, France, and Italy, is reinforcing adoption of pediatric-specific neurology devices. Continued capital deployment toward specialized pediatric care infrastructure and ongoing product innovation are expected to preserve this segment's growth momentum through the forecast period.

In aggregate, the interplay of demographic aging, rising neurological disease incidence, sustained technological innovation, and expanding regional healthcare investment positions the neurology devices industry for continued, steady expansion through 2030.

Latest Reports Offered by Delveinsight

capnography devices market, carcinoid tumor syndrome market, cardiac arrythmia market, chimeric antigen receptor t cell immunotherapy market, chronic hepatitis delta virus market, chronic inflammatory demyelinating polyneuropathy market, chronic inflammtory demyelinating polyneuropathy market, chronic lymphocytic leukemia market, chronic neuropathic pain market, chronic pruritus market, chronic pulmonary infections market, chronic refractory cough market, chronic renal failure market, clbp market, clear cell sarcoma market, clot management market, cluster headache market, cluster headaches market, coagulation factor deficiency market, concussion market, contusion market, 

About Delveinsight

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us

Kanishk

kkumar@delveinsight.com